EUVIMEDEUVIMED entdecken
Crossref

EE64 ALIGNMENT OF ESTIMATED ACQUISITION COSTS IN U.S. GENE THERAPY COST EFFECTIVENESS ANALYSES WITH STANDARD PRICE BENCHMARKS

Adeola S. Bakare, Anna Pelc, Mana Rahimian, Lawrence M. Brown, Marc Fleming, Vaishali Shukla, Rosa Rodriguez-monguio, Enrique Seoane-Vazquez

Value in Health · 2026-06 · 29 (6) · S75

DOI: 10.1016/j.jval.2026.03.359 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Value in Health, 2026-06. Verfasst von Adeola S. Bakare und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Bakare, A. S., Pelc, A., Rahimian, M., Brown, L. M., Fleming, M., Shukla, V., Rodriguez-monguio, R., & Seoane-Vazquez, E. (2026). EE64 ALIGNMENT OF ESTIMATED ACQUISITION COSTS IN U.S. GENE THERAPY COST EFFECTIVENESS ANALYSES WITH STANDARD PRICE BENCHMARKS. Value in Health, 29(6), S75. https://doi.org/10.1016/j.jval.2026.03.359

Vancouver

Bakare AS, Pelc A, Rahimian M, Brown LM, Fleming M, Shukla V, et al. EE64 ALIGNMENT OF ESTIMATED ACQUISITION COSTS IN U.S. GENE THERAPY COST EFFECTIVENESS ANALYSES WITH STANDARD PRICE BENCHMARKS. Value in Health. 2026;29(6):S75. doi:10.1016/j.jval.2026.03.359

BibTeX
@article{Bakare2026,
  author = {Bakare, Adeola S. and Pelc, Anna and Rahimian, Mana and Brown, Lawrence M. and Fleming, Marc and Shukla, Vaishali and Rodriguez-monguio, Rosa and Seoane-Vazquez, Enrique},
  title = {EE64 ALIGNMENT OF ESTIMATED ACQUISITION COSTS IN U.S. GENE THERAPY COST EFFECTIVENESS ANALYSES WITH STANDARD PRICE BENCHMARKS},
  journal = {Value in Health},
  year = {2026},
  volume = {29},
  number = {6},
  pages = {S75},
  doi = {10.1016/j.jval.2026.03.359}
}
Kostenlos starten →